- Technology and Data
- Front End Sales and Marketing
- Allergy
- HIV
- Women's Health
- Migraine
- Compounding
- Continuous Glucose Monitoring
- Mental Health Awareness
- Veterinary Pharmacy
- CBD
- Infectious Disease
- Eye Health
- Digestive Health
- Biosimilars
- Influenza
- Shingles
- COPD Management
- Pediatrics
- Generics
- Pain Management
- COVID-19
- Immunization
- Oncology
- Anticoagulants
- Autoimmune Diseases
- Dermatology
- Diabetes
- Respiratory
- Heart Health
- Cardiovascular Clinical Consult
Semingson named United Drugs CEO
United Drugs, an independent pharmacy cooperative, has announced the appointment of Bruce A. Semingson, R.Ph., FACA, as its new CEO. Formerly VP of managed care, Semingson is one of United Drugs' founding members and serves on the board of advisers to Community Care Rx. He is also on the professional practice committee of the Academy of Managed Care Pharmacy. "We couldn't be in more capable hands," said Gary Glisson, R.Ph., United Drugs' chairman of the board. "Bruce has not only developed our managed care division to become the leader in the industry, but, simply put, his knowledge of independent pharmacy and the challenges we all face is second to none."
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
